Lexology November 7, 2024
Questel

In the realm of clinical research, transparency and accessibility are key to communicating complex data to a broader audience. Lay summaries play a vital role in bridging the knowledge gap by translating intricate clinical trial data into language that is clear and accessible to non-specialist readers. This is essential not only for meeting regulatory requirements but also for fostering trust and understanding within patient communities and the general public.

In this blog, we’ll explore the importance of translating lay summaries, best practices for creating them, and introduce you to our guide, Effective Lay Summaries: Guidelines for Creation and Translation.

What Are Lay Summaries and Why Are They Important?

A lay summary is a simplified version of clinical trial results, written...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Trends
Veeva Commercial Summit: Increased investment in medical affairs by pharma companies
Non-binding Guidance: Clinical Trial Diversity in Focus
NIH algorithm matches patients to clinical trials
GLP-1 reduced heart failure risk by 46%: 8 study takeaways
Pregnant People Can Freely Make Decisions About Participation In Clinical Research

Share This Article